STXS (STOCKS)
Stereotaxis, Inc. Common Stock
$1.925000
+0.055000 (+2.94%)
Prev close: $1.870000
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- David Leo Fischel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $187.20M
- Employees
- 139
- P/E (TTM)
- -7.63
- P/B (TTM)
- 13.22
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.06 | $-0.07 | +0.0067 | +10.05% |
|
Sep 2025 (Q3)
|
$-0.07 | $-0.06 | -0.0088 | -14.38% |
|
Jun 2025 (Q2)
|
$-0.05 | $-0.07 | +0.0163 | +24.59% |
|
Mar 2025 (Q1)
|
$-0.07 | $-0.07 | +0.0040 | +5.41% |
Financial Statements
| Revenues | $32.38M |
| Benefits Costs and Expenses | $0.00 |
| Cost Of Revenue | $15.31M |
| Costs And Expenses | $54.49M |
| Gross Profit | $17.07M |
| Operating Expenses | $39.18M |
| Research and Development | $9.38M |
| Other Operating Expenses | $29.80M |
| Operating Income/Loss | -$22.11M |
| Income/Loss From Continuing Operations After Tax | -$21.64M |
| Income/Loss From Continuing Operations Before Tax | $32.38M |
| Income Tax Expense/Benefit | $2.20M |
| Income Tax Expense/Benefit, Deferred | $2.20M |
| Interest Income/Expense After Provision For Losses | $467.00K |
| Interest Income/Expense Operating, Net | $467.00K |
| Net Income/Loss | -$21.64M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$21.64M |
| Net Income/Loss Available To Common Stockholders, Basic | -$22.91M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $1.27M |
| Preferred Stock Dividends And Other Adjustments | $1.27M |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Basic Earnings Per Share | -$0.25 |
| Diluted Earnings Per Share | -$0.25 |
| Basic Average Shares | 90,957,313 |
| Diluted Average Shares | 90,957,313 |
| Assets | $52.25M |
| Current Assets | $33.85M |
| Inventory | $9.57M |
| Other Current Assets | $24.28M |
| Noncurrent Assets | $18.40M |
| Fixed Assets | $3.02M |
| Other Non-current Assets | $15.38M |
| Liabilities | $33.53M |
| Current Liabilities | $22.36M |
| Accounts Payable | $4.77M |
| Other Current Liabilities | $17.59M |
| Noncurrent Liabilities | $11.17M |
| Equity | $13.48M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $13.48M |
| Temporary Equity | $5.24M |
| Temporary Equity Attributable To Parent | $5.24M |
| Liabilities And Equity | $52.25M |
| Net Cash Flow From Operating Activities | -$13.69M |
| Net Cash Flow From Operating Activities, Continuing | -$13.69M |
| Net Cash Flow From Investing Activities | -$93.00K |
| Net Cash Flow From Investing Activities, Continuing | -$93.00K |
| Net Cash Flow From Financing Activities | $14.76M |
| Net Cash Flow From Financing Activities, Continuing | $14.76M |
| Net Cash Flow | $985.00K |
| Net Cash Flow, Continuing | $985.00K |
| Comprehensive Income/Loss | -$21.64M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$21.64M |
| Other Comprehensive Income/Loss | $0.00 |